- Nachrichtendetail
-
11.03.2024 14:06:55 - dpa-AFX: *ASTELLAS PHARMA RECEIVES FDA EXCLUSIVITIES FOR CRESEMBA IN PEDIATRIC PATIENTS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
ASTELLAS PHARMA INC. | 856273 | Frankfurt | 8,916 | 25.06.24 09:14:03 | +0,106 | +1,20% | 8,950 | 9,396 | 8,916 | 8,810 |
